Last reviewed · How we verify
NCT02304861
Viscoat Versus Visthesia. A Comparative Study of Post-cataract Endothelial Cell Loss
NA trial testing Viscoat in Cataract in 80 participants. Completed in 1 November 2014.
1 June 2014
Quick facts
| Lead sponsor | Democritus University of Thrace |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Enrollment | 80 |
| Start date | 1 January 2014 |
| Primary completion | 1 June 2014 |
| Estimated completion | 1 November 2014 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- Viscoat — full drug profile →
- Visthesia
Conditions studied
- Cataract — all drugs for Cataract →
Sponsor
Democritus University of Thrace
Who can join
Adults 55 to 85, any sex, with Cataract. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Endothelial Cell Count (ECD)
Time frame: 3 months postoperatively
Sponsor's own description
Objective of this study is the comparative assessment of the beneficial impact of the Viscoat viscoelastic (OVD) and Visthesia OVD on endothelial cells and corneal edema following torsional-ip cataract extraction surgery. Participants will be recruited from the Cataract Service of the University Hospital of Alexandroupolis (UHA) in a consecutive-if-eligible basis. Eligibility criteria include diagnosis of senile cataract with stage 3 nuclear opalescence according to the Lens Opacities Classification System III (LOCS-3) grading scale. By means of a custom computer randomization program all participants will randomly populate two study groups according to the OVD used (ie. viscoat or visthesia).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Heterologous production of chondroitin.
Couto MR, Rodrigues JL, Rodrigues LR. · · 2022 · cited 8× · PMID 35242620 · DOI 10.1016/j.btre.2022.e00710
Verify or expand the search:
- PubMed search for NCT02304861
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Viscoat
Trials testing the same drug.
- NCT00972621 — Clinical Evaluation of a New Viscoelastic for Cataract Surgery · NA · completed
Other recruiting trials for Cataract
Currently open trials in the same condition.
- NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
- NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
- NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
- NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
- NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
Other Democritus University of Thrace trials
Trials by the same sponsor.
- NCT07077967 — Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs · recruiting
- NCT07060196 — The Impact of Artificial Lighting on the Visual Capacity of Patients With Age-Related Macular Degeneration · not yet recruiting
- NCT07061431 — In Vitro and in Vivo Evaluation of the Anti-Inflammatory and Antithrombotic Synergy of Vitamin C and Bioflavonoids in He · NA · completed
- NCT07439835 — Evaluation of the Visual Acuity Curves of an Enhanced Monofocal Intraocular Lens · completed
- NCT06460389 — Visual Outcomes After Extended Depth of Focus Intraocular Lens Implantation With and Without Digital Assistance · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02304861 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Democritus University of Thrace
- Last refreshed: 14 January 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02304861.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing